Organizations such as the Veteran Mental Health Leadership Coalition and the nonprofit Reason for Hope have delved into scientific research, exploring the cautious use of psychedelic treatments—such as psilocybin, ayahuasca, MDMA, and ketamine—to address PTSD and mitigate the risk of veteran suicide. Research indicates that psychedelic substances promote the formation of new neural connections and enhance neuroplasticity, facilitating patients in confronting challenging topics and alleviating trauma symptoms.